Maravai Lifesciences Holdings, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
MRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10770 Wateridge Circle Suite 200, San Diego, CA

Insiders trading volume in the past year

Maravai Lifesciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gtcr Investment Xi Llc Director, 10%+ Owner $1.39B -$97.6M -6.55% May 28, 2024
William E. Martin III Chief Executive Officer $8.2M Oct 15, 2024
Peter Leddy Chief Administrative Officer $3.29M Jul 15, 2024
Carl Hull Executive Chairman, Director $2.69M +$987K +57.9% Nov 11, 2024
Andrew Burch President, Nucleic Acid Production $2.41M Oct 31, 2024
Kevin Herde Chief Financial Officer $1.92M Oct 31, 2024
Rebecca Buzzeo Chief Commercial Officer $1.59M Nov 15, 2024
Christine Dolan Executive Vice President & General Manager, Cygnus Technologies $1.48M Oct 31, 2024
Kurt Oreshack General Counsel $1.28M Oct 31, 2024
Jessica Hopfield Director $1.19M May 23, 2024
Susannah Gray Director $871K May 23, 2024
Murali Prahalad Director $706K May 23, 2024
Anat Ashkenazi Director $655K May 23, 2024
R. Andrew Eckert Director $594K Dec 16, 2024
Benjamin Daverman Director $527K May 23, 2024
Constantine S. Mihas Director $527K May 23, 2024
Sean Laurence Cunningham Director $527K May 23, 2024
Luke Marker Director $527K May 23, 2024
John DeFord Director $403K +$101K +33.3% Nov 12, 2024
Gregory T. Lucier Director $335K Dec 9, 2024
Robert B. Hance Director $136K Nov 19, 2021
Brian Neel Chief Operating Officer, Nucleic Acid Production $85.5K Feb 15, 2023

Recent Insider Transactions by Companies or Individuals for Maravai Lifesciences Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.